Business Context and Reporting Period
Company: Community Healthcare Trust Inc (CHCT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: A self-administered, self-managed healthcare REIT owning 198 properties (approx. 4.5 million sq. ft.) leased to hospitals and healthcare providers across 35 states. As of June 30, 2024, the portfolio was 92.6% leased with a weighted average remaining lease term of 7.1 years.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2024 |
Six Months Ended June 30, 2024 |
Six Months Ended June 30, 2023 |
|---|---|---|---|
| Total Revenues | $27,516 | $56,849 | $54,986 |
| Net (Loss) Income | $(10,427) | $(6,762) | $(345) |
| Funds from Operations (FFO) | $11,608 | $25,651 | $18,036 |
| Adjusted FFO (AFFO) | $14,281 | $29,993 | $31,632 |
| Net Operating Income (NOI) | $21,944 | $45,486 | $45,327 |
| Operating Cash Flow | N/A | $29,372 | $29,374 |
| Total Debt, Net | $457,625 | $457,625 | $403,256 (Dec 31, 2023) |
| Cash & Equivalents | $734 | $734 | $3,676 (Dec 31, 2023) |
Note: Per share data for the six months ended June 30, 2024: Net Loss $(0.31), FFO $0.96, AFFO $1.12.
Material Changes vs. Prior Period
- Net Loss: The Company reported a net loss of $10.4 million for Q2 2024 compared to net income of $6.6 million in Q2 2023. This reversal is primarily driven by an $11.0 million credit loss reserve recorded in Q2 2024.
- Revenues: Rental income increased 4.3% ($1.1 million) in Q2 2024 due to acquisitions, partially offset by a $1.9 million reduction in rental income from placing a tenant on a cash basis.
- Expenses: Interest expense increased 44.6% ($1.8 million) in Q2 2024 due to higher balances on the revolving credit facility and rising interest rates. General and administrative expenses increased 25.7% due to new executive compensation programs, though this was lower than the prior year's six-month period which included $11.8 million in accelerated stock-based compensation.
- Debt: Total debt increased to $457.6 million from $403.3 million at year-end 2023, driven by increased utilization of the revolving credit facility ($109.0 million outstanding) to fund acquisitions.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items
- Credit Loss Reserve: Recorded an $11.0 million reserve on notes receivable related to a geriatric inpatient behavioral hospital tenant due to collectability concerns (patient census and staffing challenges). The tenant was placed on non-accrual status.
- Impairment: Recorded a $140,000 impairment on a real estate asset held for sale.
- Stock-Based Compensation: Q2 2023 included $11.8 million in accelerated amortization related to the passing of the former CEO, creating a non-comparable baseline for G&A expenses.
Outlook and Pipeline
- Acquisitions: Acquired 5 properties in the first half of 2024 for ~$57.7 million. Has 7 properties under definitive purchase agreements totaling ~$169.5 million, with expected returns of 9.1% to 9.75%.
- Dividends: Declared a quarterly dividend of $0.4625 per share (annualized $1.85) on July 25, 2024.
- Liquidity: Maintains $41.0 million of remaining borrowing capacity on its $150 million revolving credit facility. Debt-to-total capitalization ratio is 38.9%.
Risks
- Tenant credit risk, specifically regarding the behavioral hospital tenant noted above.
- Interest rate volatility impacting variable-rate debt costs.
- General healthcare industry trends and regulatory changes.
Investor Verification Checklist
- Credit Loss Recovery: Verify the status of the $11.0 million credit loss reserve and the likelihood of recovery from the collateral-dependent tenant.
- Debt Covenants: Confirm continued compliance with financial covenants under the Credit Facility given the increased leverage and interest expense.
- Acquisition Pipeline: Monitor the closing timeline and funding sources for the $169.5 million acquisition pipeline.
- Occupancy Trends: Track the impact of the tenant placed on cash basis on overall portfolio occupancy and rental income stability.
- Interest Rate Hedging: Review the effectiveness of the $350 million in interest rate swaps in mitigating rising rate costs.